US Patent Issued to THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV on Feb. 10 for "VDAC inhibitors for treating inflammatory bowel diseases" (Israeli Inventor)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,421, issued on Feb. 10, was assigned to THE NATIONAL INSTITUTE FOR BIOTECHNOLOGY IN THE NEGEV LTD. (Beer-Sheva, Israel).

"VDAC inhibitors for treating inflammatory bowel diseases" was invented by Varda Shoshan-Barmatz (Omer, Israel).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to methods for treating inflammatory bowel disease (IBD). Particularly, the present invention relates to use of specific inhibitors of Voltage-Dependent Anion Channel (VDAC1), such as piperazine- and/or piperidine-derivatives, among others, e.g., peptides and oligonucleotides, for treating IBD."

The patent was filed on Nov. 26, 2019, under Appli...